Offer - Urjas Oil for just ₹ 1 X
Rospitril Plus 3 Tablet MD, a prescription drug, is manufactured in various forms such as Tablet. Rospitril Plus 3 Tablet MD also has some secondary and off-label uses. These are listed below.
The right dosage of Rospitril Plus 3 Tablet MD depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Common side effects of Rospitril Plus 3 Tablet MD include Dry Mouth. Some other side effects of Rospitril Plus 3 Tablet MD have been listed ahead. Usually, these side effects of Rospitril Plus 3 Tablet MD go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Rospitril Plus 3 Tablet MD's effect during pregnancy is Moderate and Severe while nursing. It is important to know if Rospitril Plus 3 Tablet MD has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Rospitril Plus 3 Tablet MD related warnings section.
Rospitril Plus 3 Tablet MD can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Rospitril Plus 3 Tablet MD in conditions like Tardive Dyskinesia, Kidney Disease, Liver Disease. Other conditions have been mentioned below in the Rospitril Plus 3 Tablet MD contraindications section.
Besides this, Rospitril Plus 3 Tablet MD may also have severe interaction with some medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Rospitril Plus 3 Tablet MD is considered not safe while driving, and is not addictive.
Rospitril Plus 3 Tablet MD is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Rospitril Plus 3 Tablet MD safe for pregnant women?
Rospitril Plus can have harmful effects in pregnant women. If you experience any discomfort after using Rospitril Plus, then discontinue the use and take your doctor's advice.
Is the use of Rospitril Plus 3 Tablet MD safe during breastfeeding?
Rospitril Plus should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Rospitril Plus 3 Tablet MD on the Kidneys?
Rospitril Plus rarely harms the kidneys.
What is the effect of Rospitril Plus 3 Tablet MD on the Liver?
Rospitril Plus has very mild side effects on the liver.
What is the effect of Rospitril Plus 3 Tablet MD on the Heart?
Rospitril Plus is not harmful for the heart.
Rospitril Plus 3 Tablet MD should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Rospitril Plus 3 Tablet MD unless your doctor advises you to do so -
Is this Rospitril Plus 3 Tablet MD habit forming or addictive?
No, there is no any evidence that Rospitril Plus 3 Tablet MD is addictive.
Interaction between Food and Rospitril Plus 3 Tablet MD
Taking Rospitril Plus 3 Tablet MD with food does not harm your health.
Interaction between Alcohol and Rospitril Plus 3 Tablet MD
Consult your doctor before consuming alcohol while taking Rospitril Plus 3 Tablet MD as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Risperdal® (risperidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 441-442
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1101-1103
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 433
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Trihexyphenidyl Hydrochloride (trihexyphenidyl hydrochloride)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Artane (trihexyphenidyl hydrochloride)